Cohort Profile: The Swiss Childhood Cancer Survivor Study

Abstract

Thanks to continuous improvements in therapy, 5-year survival of childhood cancer in developed countries now exceeds 80%,^1,2 leading to a growing population of long-term survivors. As the cancer and treatment can cause adverse effects long after the illness has been cured, assessment of long-term quality of life (QOL), somatic, psychological and social outcomes become increasingly important. Although cancer in children is rare, the population impact of late toxicities on disability-adjusted life years is considerable because of the young age at diagnosis.